Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: ICN Pharmaceuticals

No earlier versions found for this Subject.

Return to ICN Pharmaceuticals

Strong rumors of buyout by Schering Plough or other (Lilly? , Bristol Myers?) to give the CEO a sackful of dollars as he is zapped out of the CEO job and presumably heads outta the states; near term (under investigation by FBI, SEC, LA Grand Jury). Projected sale price $40-50/sh, based on future approval of Ribavarin (joint venture with Schering), Eastern Europe sales and connections, and advantageous tax loss carryforward. Anyone tuned in; anything to add? This story sound like someone's smoking pot? Thanks for your feedback!